Evaluation of a novel aminopeptidase N inhibitor, in vitro, using two assay systems

References

• Churchill L, Bausback HH, Gerritsen ME, Ward PE. Metabolism of opioid peptide by cerebral microvascular aminopeptidase. M Biochem Biophys Acta 1987; 923: 35–41
   PubMed Web of Science ®Google Scholar
• Erickson JA, Jalie M, Robertson DH, Lewis RA, Vieh M. Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy. J Med Chem 2004; 47: 45–55
   PubMed Web of Science ®Google Scholar
• Fournie'-Zaluski MC, Chaillet P, Bouboutou R, Coulaud A, Cherot P, Waksman G, Costentin J, Roques BP. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Eur J Pharmacol 1984; 102: 525–528
   PubMedGoogle Scholar
• Glavas-Obrovac L, Jkas A, Marczi S, Horvat S. The influence of cell growth media on the stability and antitumour activity of methionine enkephalin. J Pept Sci 2005; 11: 506–511
   PubMedGoogle Scholar
• Glowinski J, Lyersen LL. Regional studies of catecholamines in the rat brain-1: The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. 1. J Neurochem 1966; 13: 655–669
   PubMed Web of Science ®Google Scholar
• Hiranuma T, Iwao K, Kitamura K, Matsumiya T, Oka T. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. J Pharmacol Exp Ther 1997; 281: 769–774
   PubMedGoogle Scholar
• Hiranuma T, Kitamura K, Taniguchi T, Kanai M, Arai Y, Iwao K, Oka T. Protection against dynorphin-(1–8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. J Pharmacol Exp Ther 1998; 286: 863–869
   PubMedGoogle Scholar
• Jaba IM, Vasincu D, Manolidis G, Haulica I, Mungiu OC. Experimental data regarding the implications of certain minimum structure enkephalin-like peptides in nociceptive processing. Rom J Physiol 2004; 41: 119–126
   PubMedGoogle Scholar
• Jagloski JR, Zagon IS, Stack BC, Jr, Verderame MF, Leure-duPree AE, Manning JD, Mc Laughlin P. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 2005; 56: 97–104
   PubMedGoogle Scholar
• Jankovic BD, Maric D. Enkephalins modulate in vivo immune reactions through delta- and mu-opiod receptors. Ann N Y Acad Sci 1988; 540: 691–693
   PubMedGoogle Scholar
• Kishioka S, Miyamoto Y, Nishida S, Fukunaga Y, Yamamoto H. Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidone) on Met-enkephalin-, β-endorphin-, dynorphin-(1–13)- and electroacupuncture-induced antinociception in rats. Jpn J Pharmacol 1994; 66: 337–345
   PubMedGoogle Scholar
• Marotti T, Balog T, Munic V, Sobocanec S, Abramic M. The link between met- enkephalin-induced down-regulation of APN activity and the release of superoxide anion. Neuropeptides 2000; 34: 121–128
   PubMedGoogle Scholar
• Scornik OA, Botbol V. Bestatin as an experimental tool in mammals. Curr Drug Metab 2001; 2: 67–85
   PubMed Web of Science ®Google Scholar
• Oka T, Negishi K, Suda M, Sawa A, Fujino M, Wakimasu M. Evidence that dynophin- (1–13) acts as an agonist on opioid κ-receptors. Eur J Pharmacol 1982; 77: 137–141
   PubMed Web of Science ®Google Scholar
• Rarey M, Kramer B, Lenqauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol 1996; 261: 470–489
   PubMed Web of Science ®Google Scholar
• Rawlings ND, Barret AJ. Evolutionary families of metallopeptidases. Meth Enzymol. 1995; 248: 183–228
   PubMed Web of Science ®Google Scholar
• Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs2^nd edn. Springer-Verlag, New York 1987; 53–56
   Google Scholar
• Taniguchi T, Fan XT, Kitamura K, Oka T. Effects of peptidase inhibitors on the enkephalin-induced anti-nociception in rats. Jpn J Pharmacol 1998; 78: 487–492
   PubMedGoogle Scholar
• Thunnissen MM, Nordlund P, Haeggstrom JZ. Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation. Nat Struct Biol 2001; 8: 131–135
   PubMedGoogle Scholar
• Turer AJ, Matsas R, Kenny AJ. Are there neuropeptide-specific peptidases?. Biochem Pharmacol 1985; 34: 1347–1356
   PubMedGoogle Scholar
• Umezawa H. Low-molecular-weight enzyme inhibitors of microbial origin. Annu Rev Microbiol 1982; 36: 75
   PubMed Web of Science ®Google Scholar
• Xu J, Xin S, Li H, Liu L, Xia W, Li P, Liu X, Li G. Involvement of caspase-3 pathway in anti-apoptotic action of methionine enkephalin on CEMx174 cells in prolonged infection with simian immunodeficiency virus in vitro. Cell Bio Int 2006; 30: 114–121
   PubMedGoogle Scholar